Drug Shortage Report for NAPROSYN

Last updated on 2018-09-21 History
Report ID 52317
Drug Identification Number 02162423
Brand name NAPROSYN
Common or Proper name naproxen
Company Name SEARCHLIGHT PHARMA INC
Market Status MARKETED
Active Ingredient(s) NAPROXEN
Strength(s) 500MG
Dosage form(s) TABLET (ENTERIC-COATED)
Route of administration ORAL
Packaging size Bottles of 100 tablets
ATC code M01AE
ATC description ANTIINFLAMMATORY/ANTIRHEUMATIC PROD.,NON-STEROIDS
Reason for shortage Demand increase for the drug.
Anticipated start date
Actual start date 2018-06-13
Estimated end date 2018-09-21
Actual end date 2018-09-20
Shortage status Resolved
Updated date 2018-09-21
Company comments For more information, please contact Methapharm Inc. at 1-800-287-7686, sales@methapharm.com or by fax at 1-519-751-9149.
Health Canada comments
Tier 3 Status No
Contact Address 1600 RUE NOTRE DAME OUEST, SUITE 312
MONTREAL, QUEBEC
CANADA H3J 1M1
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v8 2018-09-21 English Compare
v7 2018-09-20 French Compare
v6 2018-09-20 English Compare
v5 2018-08-24 French Compare
v4 2018-08-24 English Compare
v3 2018-06-14 English Compare
v2 2018-06-13 French Compare
v1 2018-06-13 English Compare

Showing 1 to 8 of 8